Unresectable and locally advanced biliary cancer
Conditions
Interventions
Radiation with Gemcitabine administration
Sponsors
Osaka University, Graduate School of Medicine, GE Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Unresectable locally advanced bilary cancer PS0-1 Hb>10.0 WBC 4000-12000/uL Neu >2000/uL PLT >100000/uL AST, ALT <x2.5 or <x3 of normal with obstractive jaundice (OJ) T.Bil <x2 or <x3 of normal with OJ crtn W.N.L
Exclusion criteria
Exclusion criteria: Interstitial Pneumonia Infection Heart Failure DM Allergy Other Severe Complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy | — |
Countries
Japan
Contacts
Public ContactShogo Kobayashi
Osaka University GE Surgery
Outcome results
None listed